Literature DB >> 16785477

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

Franz H Messerli1, Giuseppe Mancia, C Richard Conti, Ann C Hewkin, Stuart Kupfer, Annette Champion, Rainer Kolloch, Athanase Benetos, Carl J Pepine.   

Abstract

BACKGROUND: Because coronary perfusion occurs mainly during diastole, patients with coronary artery disease (CAD) could be at increased risk for coronary events if diastolic pressure falls below critical levels.
OBJECTIVE: To determine whether low blood pressure could be associated with excess mortality and morbidity in this population.
DESIGN: A secondary analysis of data from the International Verapamil-Trandolapril Study (INVEST), which was conducted from September 1997 to February 2003.
SETTING: 862 sites in 14 countries. PATIENTS: 22 576 patients with hypertension and CAD.
INTERVENTIONS: Patients from INVEST were randomly assigned to a verapamil sustained-release- or atenolol-based strategy; blood pressure control and outcomes were equivalent. MEASUREMENTS: An unadjusted quadratic proportional hazards model was used to evaluate the relationship between average on-treatment blood pressure and risk for the primary outcome (all-cause death, nonfatal stroke, and nonfatal myocardial infarction [MI]), all-cause death, total MI, and total stroke. A second model adjusted for differences in baseline covariates.
RESULTS: The relationship between blood pressure and the primary outcome, all-cause death, and total MI was J-shaped, particularly for diastolic pressure, with a nadir at 119/84 mm Hg. After adjustment, the J-shaped relationship persisted between diastolic pressure and primary outcome. The MI-stroke ratio remained constant over a wide blood pressure range, but at a lower diastolic blood pressure, there were substantially more MIs than strokes. An interaction between decreased diastolic pressure and history of revascularization was observed; low diastolic pressure was associated with a relatively lower risk for the primary outcome in patients with revascularization than in those without revascularization. LIMITATIONS: This is a post hoc analysis of hypertensive patients with CAD.
CONCLUSIONS: The risk for the primary outcome, all-cause death, and MI, but not stroke, progressively increased with low diastolic blood pressure. Excessive reduction in diastolic pressure should be avoided in patients with CAD who are being treated for hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785477     DOI: 10.7326/0003-4819-144-12-200606200-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  195 in total

1.  [Arterial hypertension in patients with coronary artery disease].

Authors:  T Graf; H Schunkert
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

2.  On redefining hypertension.

Authors:  Michel Accad; Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2010

Review 3.  Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease.

Authors:  Monisankar Roy; Noman Mahmood; Clive Rosendorff
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

Review 4.  The optimal blood pressure target for patients with coronary artery disease.

Authors:  Paolo Verdecchia; Fabio Angeli; Claudio Cavallini; Giovanni Mazzotta; Marta Garofoli; Paola Martire; Gianpaolo Reboldi
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

Review 5.  Novel therapeutic targets for hypertension.

Authors:  Ludovit Paulis; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

Review 6.  Blood pressure lowering in patients with diabetes--one level might not fit all.

Authors:  Rhonda M Cooper-DeHoff; Eric F Egelund; Carl J Pepine
Journal:  Nat Rev Cardiol       Date:  2010-11-16       Impact factor: 32.419

7.  Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease.

Authors:  Miklos Z Molnar; Lilia R Lukowsky; Elani Streja; Ramanath Dukkipati; Jennie Jing; Allen R Nissenson; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

8.  Relation of Diastolic Blood Pressure and Coronary Artery Calcium to Coronary Events and Outcomes (From the Multi-Ethnic Study of Atherosclerosis).

Authors:  Faisal Rahman; Mahmoud Al Rifai; Michael J Blaha; Khurram Nasir; Matthew J Budoff; Bruce M Psaty; Wendy S Post; Roger S Blumenthal; John W McEvoy
Journal:  Am J Cardiol       Date:  2017-08-08       Impact factor: 2.778

9.  Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.

Authors:  Scott J Denardo; Franz H Messerli; Efrain Gaxiola; Juan M Aranda; Rhonda M Cooper-Dehoff; Eileen M Handberg; Yan Gong; Annette Champion; Qian Zhou; Carl J Pepine
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

10.  Efficacy of pentoxifylline for reduction of proteinuria in type II diabetic patients.

Authors:  Farshid Oliaei; Shirin Hushmand; Soraya Khafri; Mahmoud Baradaran
Journal:  Caspian J Intern Med       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.